id	sid	eid	entity	type
admet-882	1	1	http://dx.doi.org/10.5599/admet.882 41 admet &	ORG
admet-882	1	2	9(1	CARDINAL
admet-882	1	3	2021	CARDINAL
admet-882	1	4	41	CARDINAL
admet-882	1	5	issn	PERSON
admet-882	1	6	1848-7718	DATE
admet-882	1	7	abigail ferreira1,2	PERSON
admet-882	1	8	sara moreira1,3	PERSON
admet-882	1	9	rui lapa2	PERSON
admet-882	1	10	nuno	DATE
admet-882	1	11	1	CARDINAL
admet-882	1	12	rua dr	PERSON
admet-882	1	13	plácido da costa	PERSON
admet-882	1	14	4200	CARDINAL
admet-882	1	15	portugal 2 laqv	ORG
admet-882	1	16	university of porto	ORG
admet-882	1	17	rua de jorge viterbo ferreira	PERSON
admet-882	1	18	228	CARDINAL
admet-882	1	19	4050	CARDINAL
admet-882	1	20	portugal 3	ORG
admet-882	1	21	university of porto	ORG
admet-882	1	22	rua	GPE
admet-882	1	23	campo alegre	PERSON
admet-882	1	24	687	CARDINAL
admet-882	1	25	4169	CARDINAL
admet-882	1	26	portugal 4	ORG
admet-882	1	27	university of porto	ORG
admet-882	1	28	al. prof	ORG
admet-882	1	29	hernâni monteiro	PERSON
admet-882	1	30	4200-319	CARDINAL
admet-882	1	31	portugal	GPE
admet-882	3	1	+351-225513600	DATE
admet-882	3	2	+351-225513601	CARDINAL
admet-882	3	3	july 04, 2020	DATE
admet-882	3	4	october 13, 2020	DATE
admet-882	3	5	october 26, 2020	DATE
admet-882	5	1	gemcitabine	PERSON
admet-882	8	1	three	CARDINAL
admet-882	11	1	cpp6-2	ORG
admet-882	11	2	caco2	LOC
admet-882	12	1	2021	CARDINAL
admet-882	15	1	second	ORDINAL
admet-882	16	1	18 million	CARDINAL
admet-882	16	2	9.6 million	CARDINAL
admet-882	16	3	2018	DATE
admet-882	17	1	about one	CARDINAL
admet-882	17	2	six	CARDINAL
admet-882	18	1	1	CARDINAL
admet-882	22	1	http://dx.doi.org/10.5599/admet.882 https://dx.doi.org/10.5599/admet.882	PRODUCT
admet-882	23	1	n. vale et al. admet	PERSON
admet-882	23	2	9(1	CARDINAL
admet-882	23	3	2021	CARDINAL
admet-882	23	4	41	CARDINAL
admet-882	23	5	2′,2′-difluoro-2′-deoxycytidine	CARDINAL
admet-882	23	6	1	CARDINAL
admet-882	24	1	first	ORDINAL
admet-882	24	2	2	CARDINAL
admet-882	25	1	half	CARDINAL
admet-882	25	2	8-17 min	TIME
admet-882	25	3	4-n	QUANTITY
admet-882	25	4	cda	ORG
admet-882	28	1	1	CARDINAL
admet-882	29	1	3	CARDINAL
admet-882	30	1	4	CARDINAL
admet-882	32	1	5	CARDINAL
admet-882	33	1	three	CARDINAL
admet-882	34	1	two	CARDINAL
admet-882	34	2	cpp5	PERSON
admet-882	34	3	klpvm	GPE
admet-882	35	1	one	CARDINAL
admet-882	35	2	cpp5	PERSON
admet-882	35	3	trp	PERSON
admet-882	35	4	7	CARDINAL
admet-882	35	5	three	CARDINAL
admet-882	35	6	cpp6-2	ORG
admet-882	35	7	cpp6-3	ORG
admet-882	37	1	cda	ORG
admet-882	37	2	4-n	QUANTITY
admet-882	38	1	5	CARDINAL
admet-882	39	1	three	CARDINAL
admet-882	43	1	9	CARDINAL
admet-882	44	1	american	NORP
admet-882	44	2	fda	ORG
admet-882	45	1	10	CARDINAL
admet-882	46	1	25	CARDINAL
admet-882	46	2	university of porto	ORG
admet-882	46	3	10 %	PERCENT
admet-882	47	1	37 °	QUANTITY
admet-882	47	2	5 %	PERCENT
admet-882	48	1	2-3 days	DATE
admet-882	48	2	0.25 %	PERCENT
admet-882	48	3	5	CARDINAL
admet-882	48	4	37	DATE
admet-882	49	1	9(1	CARDINAL
admet-882	49	2	2021	CARDINAL
admet-882	49	3	41	CARDINAL
admet-882	49	4	43	CARDINAL
admet-882	49	5	mtt	ORG
admet-882	51	1	96well	CARDINAL
admet-882	51	2	0.322	CARDINAL
admet-882	51	3	tpp®	ORG
admet-882	51	4	9.3	CARDINAL
admet-882	51	5	103	CARDINAL
admet-882	51	6	200	CARDINAL
admet-882	52	1	24	CARDINAL
admet-882	52	2	0.1	CARDINAL
admet-882	52	3	1	DATE
admet-882	52	4	5	DATE
admet-882	52	5	10	DATE
admet-882	52	6	20	DATE
admet-882	52	7	50	DATE
admet-882	52	8	100	CARDINAL
admet-882	52	9	1000	CARDINAL
admet-882	52	10	10000	DATE
admet-882	53	1	72	CARDINAL
admet-882	53	2	100	CARDINAL
admet-882	53	3	mtt	ORG
admet-882	53	4	3(4,5	CARDINAL
admet-882	55	1	mtt	ORG
admet-882	55	2	100	CARDINAL
admet-882	55	3	sinergy ht	PERSON
admet-882	55	4	biotek instruments inc	ORG
admet-882	55	5	vermont	GPE
admet-882	57	1	gemcitabine cytotoxicity	PERSON
admet-882	57	2	100 %	PERCENT
admet-882	57	3	±	CARDINAL
admet-882	58	1	7	CARDINAL
admet-882	58	2	san diego	GPE
admet-882	58	3	eua	PERSON
admet-882	58	4	one	CARDINAL
admet-882	58	5	anova	ORG
admet-882	59	1	1	CARDINAL
admet-882	59	2	three	CARDINAL
admet-882	59	3	cpp6-1	ORG
admet-882	59	4	cpp6-2	ORG
admet-882	59	5	cpp6-3	ORG
admet-882	60	1	5	CARDINAL
admet-882	61	1	cpp6-2	ORG
admet-882	61	2	cpp6-3	ORG
admet-882	61	3	wvptlk	ORG
admet-882	61	4	gemcitabine gemcitabine	PERSON
admet-882	61	5	al. admet & dmpk	ORG
admet-882	61	6	9(1	CARDINAL
admet-882	61	7	2021	CARDINAL
admet-882	61	8	41	CARDINAL
admet-882	62	1	gemcitabine	PERSON
admet-882	63	1	first	ORDINAL
admet-882	63	2	two	CARDINAL
admet-882	63	3	4-n	QUANTITY
admet-882	64	1	1	CARDINAL
admet-882	65	1	12	CARDINAL
admet-882	66	1	11	CARDINAL
admet-882	67	1	12 mm	QUANTITY
admet-882	67	2	0.4	CARDINAL
admet-882	67	3	corning inc	ORG
admet-882	67	4	corning transwell col collagen	ORG
admet-882	67	5	ny, usa	ORG
admet-882	69	1	firstly	ORDINAL
admet-882	69	2	0.1 ml	QUANTITY
admet-882	69	3	2 minutes	TIME
admet-882	70	1	0.5 ml	QUANTITY
admet-882	70	2	4.0	CARDINAL
admet-882	70	3	105	CARDINAL
admet-882	71	1	1.5 ml	QUANTITY
admet-882	71	2	6	CARDINAL
admet-882	71	3	5 %	PERCENT
admet-882	71	4	37 °	QUANTITY
admet-882	73	1	29 days	DATE
admet-882	74	1	37 °	QUANTITY
admet-882	75	1	24	CARDINAL
admet-882	76	1	first	ORDINAL
admet-882	77	1	0.5 ml	QUANTITY
admet-882	77	2	hank	ORG
admet-882	77	3	7.4	CARDINAL
admet-882	77	4	1.5 ml	QUANTITY
admet-882	78	1	17 min	TIME
admet-882	78	2	37 °	QUANTITY
admet-882	78	3	190	CARDINAL
admet-882	78	4	gfl®	ORG
admet-882	78	5	3015	CARDINAL
admet-882	80	1	0.4 ml	QUANTITY
admet-882	80	2	1.2 ml	QUANTITY
admet-882	81	1	0.45 ml	QUANTITY
admet-882	81	2	0.05 ml	QUANTITY
admet-882	82	1	37 °	QUANTITY
admet-882	82	2	190	CARDINAL
admet-882	83	1	30 min	QUANTITY
admet-882	83	2	the next 2 h	DATE
admet-882	83	3	0.6 ml	QUANTITY
admet-882	84	1	120 min	QUANTITY
admet-882	84	2	0.05 ml	QUANTITY
admet-882	85	1	vwr international lcc	ORG
admet-882	85	2	pennsylvania	GPE
admet-882	86	1	0.05 %	PERCENT
admet-882	86	2	0.7 ml	QUANTITY
admet-882	86	3	243	CARDINAL
admet-882	86	4	220	CARDINAL
admet-882	88	1	1	CARDINAL
admet-882	90	1	ic50	ORG
admet-882	90	2	52.4 µm	MONEY
admet-882	91	1	9(1	CARDINAL
admet-882	91	2	2021	CARDINAL
admet-882	91	3	41	CARDINAL
admet-882	91	4	45	CARDINAL
admet-882	91	5	1	CARDINAL
admet-882	93	1	±	CARDINAL
admet-882	93	2	one	CARDINAL
admet-882	93	3	anova	ORG
admet-882	96	1	30 minutes	TIME
admet-882	96	2	just 3 %	PERCENT
admet-882	97	1	90 min	QUANTITY
admet-882	97	2	only an additional 1 %	PERCENT
admet-882	97	3	120 min	QUANTITY
admet-882	97	4	18 %	PERCENT
admet-882	98	1	3	CARDINAL
admet-882	98	2	120 minutes	TIME
admet-882	99	1	cpp62	ORG
admet-882	99	2	40 %	PERCENT
admet-882	99	3	cpp6-3	ORG
admet-882	99	4	37 %	PERCENT
admet-882	99	5	cpp6-1	ORG
admet-882	99	6	33 %	PERCENT
admet-882	100	1	the first 30 minutes	TIME
admet-882	100	2	4 to 5 %	PERCENT
admet-882	100	3	between 30 and 90 minutes	CARDINAL
admet-882	101	1	the last 30 minutes	TIME
admet-882	102	1	cpp6-1	ORG
admet-882	102	2	2	CARDINAL
admet-882	103	1	84 %	PERCENT
admet-882	103	2	cpp6-2,	ORG
admet-882	103	3	75 %	PERCENT
admet-882	103	4	cpp6-3 and 50 %	ORG
admet-882	103	5	cpp6-1	ORG
admet-882	104	1	al. admet & dmpk	ORG
admet-882	104	2	9(1	CARDINAL
admet-882	104	3	2021	CARDINAL
admet-882	104	4	41	CARDINAL
admet-882	105	1	2	CARDINAL
admet-882	105	2	60	CARDINAL
admet-882	107	1	about 3fold	CARDINAL
admet-882	108	1	approximately 31 %	PERCENT
admet-882	108	2	only 9 %	PERCENT
admet-882	108	3	3	CARDINAL
admet-882	109	1	cpp6-2	ORG
admet-882	110	1	three	CARDINAL
admet-882	110	2	cpp6-2	ORG
admet-882	111	1	cpp6-2	ORG
admet-882	114	1	12-15	CARDINAL
admet-882	115	1	2 trp	QUANTITY
admet-882	116	1	16	CARDINAL
admet-882	117	1	rydberg et al	PERSON
admet-882	117	2	12	CARDINAL
admet-882	119	1	1	CARDINAL
admet-882	120	1	9(1	CARDINAL
admet-882	120	2	2021	CARDINAL
admet-882	120	3	41	CARDINAL
admet-882	120	4	47	CARDINAL
admet-882	120	5	3	CARDINAL
admet-882	122	1	1	CARDINAL
admet-882	123	1	-6	DATE
admet-882	123	2	247.63	CARDINAL
admet-882	123	3	1.326	CARDINAL
admet-882	123	4	1.31	CARDINAL
admet-882	123	5	1.326	CARDINAL
admet-882	123	6	3.1.0.30	CARDINAL
admet-882	123	7	lancaster	GPE
admet-882	123	8	california	GPE
admet-882	123	9	9.5	CARDINAL
admet-882	123	10	lancaster	GPE
admet-882	123	11	california	GPE
admet-882	123	12	0.011	CARDINAL
admet-882	123	13	0.278 x	QUANTITY
admet-882	124	1	17	CARDINAL
admet-882	128	1	cpp6-2	ORG
admet-882	130	1	fundo europeu de desenvolvimento	PERSON
admet-882	130	2	2020	DATE
admet-882	130	3	portugal 2020	ORG
admet-882	130	4	portuguese	NORP
admet-882	130	5	fct	ORG
admet-882	130	6	ciência e	ORG
admet-882	131	1	n.v.	PERSON
admet-882	132	1	fct	ORG
admet-882	132	2	european union	ORG
admet-882	134	1	fct	ORG
admet-882	135	1	fct	ORG
admet-882	137	1	http://dx.doi.org/10.5599/admet.882 n. vale et al. admet &	ORG
admet-882	137	2	9(1	CARDINAL
admet-882	137	3	2021	CARDINAL
admet-882	137	4	41	CARDINAL
admet-882	137	5	1	CARDINAL
admet-882	137	6	2018	DATE
admet-882	137	7	2018	DATE
admet-882	138	1	june 10, 2020	DATE
admet-882	139	1	2	CARDINAL
admet-882	139	2	a. wong	PERSON
admet-882	139	3	r.a.	PERSON
admet-882	140	1	yong, f. innocenti	ORG
admet-882	142	1	41	CARDINAL
admet-882	142	2	2009	DATE
admet-882	142	3	77-88	DATE
admet-882	143	1	3	CARDINAL
admet-882	143	2	s. nobili	PERSON
admet-882	143	3	b. caciagli	PERSON
admet-882	143	4	i. landini	PERSON
admet-882	143	5	t. mazzei	ORG
admet-882	144	1	2006	DATE
admet-882	144	2	7	CARDINAL
admet-882	145	1	4	CARDINAL
admet-882	145	2	e. moysan	PERSON
admet-882	145	3	g. bastiat	PERSON
admet-882	145	4	j.-p	GPE
admet-882	146	1	benoit	PERSON
admet-882	147	1	gemcitabine versus	PERSON
admet-882	148	1	10 (2013	DATE
admet-882	148	2	430	CARDINAL
admet-882	149	1	5	CARDINAL
admet-882	149	2	c. correia	PERSON
admet-882	149	3	c.p.r	PERSON
admet-882	150	1	xavier	PERSON
admet-882	150	2	d. duarte	GPE
admet-882	150	3	a. ferreira	PERSON
admet-882	150	4	s. moreira	PERSON
admet-882	150	5	m.h. vasconcelos	PERSON
admet-882	150	6	n. vale.	ORG
admet-882	152	1	rsc medicinal chemistry	ORG
admet-882	152	2	11	CARDINAL
admet-882	152	3	2020	DATE
admet-882	152	4	268	CARDINAL
admet-882	152	5	273	CARDINAL
admet-882	153	1	6	CARDINAL
admet-882	153	2	a. ferreira	PERSON
admet-882	153	3	i. fernandes	PERSON
admet-882	153	4	c. alves	PERSON
admet-882	153	5	m.j. araujo	PERSON
admet-882	153	6	n. mateus	PERSON
admet-882	155	1	bioorganic	ORG
admet-882	155	2	27	CARDINAL
admet-882	155	3	2017	CARDINAL
admet-882	155	4	2898-2901	CARDINAL
admet-882	156	1	7	CARDINAL
admet-882	156	2	k. kachel	PERSON
admet-882	156	3	e. asuncion-punzalan	PERSON
admet-882	156	4	e. london	PERSON
admet-882	158	1	34 (1995	DATE
admet-882	158	2	15475-15479	DATE
admet-882	159	1	8	CARDINAL
admet-882	159	2	r.f.	GPE
admet-882	159	3	h.j. vogel	GPE
admet-882	159	4	r.m.	GPE
admet-882	159	5	epand	PERSON
admet-882	160	1	80	CARDINAL
admet-882	160	2	2002	DATE
admet-882	160	3	667	CARDINAL
admet-882	161	1	9	CARDINAL
admet-882	161	2	angelis	PERSON
admet-882	161	3	l. turco	PERSON
admet-882	163	1	47	DATE
admet-882	163	2	2011	DATE
admet-882	163	3	20.6.1-20.6.15	TIME
admet-882	164	1	10	CARDINAL
admet-882	164	2	u.s.	GPE
admet-882	164	3	food and drug administration	ORG
admet-882	166	1	december 2017	DATE
admet-882	166	2	biopharmaceutics	ORG
admet-882	167	1	11	CARDINAL
admet-882	167	2	i. hubatsch	PERSON
admet-882	167	3	p. artursson	PERSON
admet-882	169	1	2007	DATE
admet-882	169	2	2111-2119	DATE
admet-882	170	1	12	CARDINAL
admet-882	170	2	rydberg	ORG
admet-882	170	3	m. matson	PERSON
admet-882	170	4	h.l.	GPE
admet-882	170	5	esbjorner	PERSON
admet-882	170	6	b. nordén	PERSON
admet-882	172	1	51	CARDINAL
admet-882	172	2	2012) 55315539	DATE
admet-882	173	1	13	CARDINAL
admet-882	173	2	chan	ORG
admet-882	173	3	e.j. prenner	PERSON
admet-882	173	4	h.j. vogel	PERSON
admet-882	174	1	bba)-biomembranes 1758	ORG
admet-882	174	2	2006) 11841202	DATE
admet-882	175	1	14	CARDINAL
admet-882	178	1	11	CARDINAL
admet-882	178	2	1998	DATE
admet-882	178	3	153	CARDINAL
admet-882	179	1	15	CARDINAL
admet-882	180	1	yau	PERSON
admet-882	180	2	w.c.	GPE
admet-882	180	3	wimley	PERSON
admet-882	180	4	k. gawrisch	PERSON
admet-882	182	1	37	CARDINAL
admet-882	182	2	1998	DATE
admet-882	182	3	14713-14718	DATE
admet-882	183	1	16	CARDINAL
admet-882	184	1	jobin	PERSON
admet-882	184	2	m. blanchet	PERSON
admet-882	184	3	s. henry	PERSON
admet-882	184	4	s. chaignepain	PERSON
admet-882	184	5	c. manigand	PERSON
admet-882	184	6	s. castano	PERSON
admet-882	184	7	s. lecomte	PERSON
admet-882	184	8	f. burlina	PERSON
admet-882	184	9	s. sagan	PERSON
admet-882	184	10	i.d.	GPE
admet-882	186	1	bba)-biomembranes 1848	EVENT
admet-882	186	2	2015	CARDINAL
admet-882	186	3	593	CARDINAL
admet-882	187	1	17	CARDINAL
admet-882	187	2	s. winiwarter	PERSON
admet-882	187	3	n.m. bonham	PERSON
admet-882	187	4	f. ax,	PERSON
admet-882	187	5	a. hallberg	PERSON
admet-882	187	6	h. lennernäs	PERSON
admet-882	187	7	a. karlén	PERSON
admet-882	190	1	journal of medicinal chemistry	ORG
admet-882	190	2	41	CARDINAL
admet-882	190	3	1998	DATE
admet-882	190	4	4939-4949	DATE
admet-882	191	1	2020	DATE
admet-882	191	2	iapc	ORG
admet-882	191	3	zagreb	GPE
admet-882	191	4	croatia	GPE
admet-882	192	1	http://creativecommons.org/licenses/by/3.0/	ORG
admet-882	192	2	http://creativecommons.org/licenses/by/3.0/	ORG